As officials struggle to fight the opioid epidemic that is plaguing the country, some big cities are considering creating "safe injection" sites. Addicts would be able to use their drugs under the watch of medical professionals, and they would be provided clean needles. While no city has submitted a formal plan, the idea is already stirring up controversy.
Dina Fine Maron, Health & Medicine Editor at Scientific American, explains the science behind safe injection sites. Allowing addicts to use drugs under supervision and with clean needles helps to reduce diseases associated with intravenous drug use such as HIV.
While no city in the United States has a "safe injection" site, Fine Maron says existing sites in Europe and Canada have proven to be a success. Data shows that opening these sites helps reduce opioid-related deaths and problems.
The World War II veteran who walked into the hearts of a nation in lockdown as he shuffled up and down his garden to raise money for healthcare workers has died after testing positive for COVID-19.
Pennsylvania entrepreneur Jared Isaacman aims to use the trip to raise $200 million for St. Jude Children's Research Hospital.
Does wearing two masks provide more protection?
Geraldine Barnuevo, , environmental strategies and sustainability senior manager at GM, spoke to Cheddar about what's in store for the automaker following its big pledge to go carbon neutral by 2040.
Johnson & Johnson says its vaccine appears to protect against COVID-19 with just one shot.
Event organizers and other unconventional logistics experts are using their skills to help the nation vaccinate as many people against COVID-19 as possible.
The Heat will use coronavirus-sniffing dogs at AmericanAirlines Arena to screen fans who are coming to their home games.
A new variant of the coronavirus has emerged in the United States.
John Banovetz, chief technology officer at 3M, spoke with Cheddar about how we can better prepare for future pandemics based on lessons learned from COVID.
Employers weigh the pros and cons of potentially mandating workers get the COVID vaccine or incentivizing them to get the shots, a conundrum complicated by legal considerations.
